Lucas(Hyundeok) Kang
Data Scientist
Seoul
Summary
An adept generalist who has traversed over five domains, leaving significant footprint on each stage. With a unique blend of career and academic experiences, innovative problem-solving skills have been cultivated. Furthermore, exceptional work ethic and a collaborative spirit have emerged as instrumental components of the key success factors.
Overview
8
8
years of professional experience
14
14
years of post-secondary education
Work History
Data scientist
Novartis Korea
11.2022 - Current
- Drive data driven decision making culture within team and cross-functional teams.
- Develop and deploy Account Planning Intelligence Tool (a-PIT) to equip field force to make data driven account engagement planning and decision making.
- Local implementation of Dynamic Resource Optimization (DRO) workflow and create customized call plan optimization process to address local resource optimization challenges.
- Build predictive models using time series analysis to predict new patient prescription number.
- Provide text analysis workflow to analyze medical insights generated by field medical lead.
Gene Therapy (Zolgensma) Medical Lead
Novartis Korea
03.2021 - 10.2022
- Successfully lead Zolgensma Medical team from regulatory approval to product launch.
- Developed and executed medical launch strategy by engaging and handling various external KoL (HCPs, Law makers, Public officer, PAG, Media).
- Designed and implement RWE study to bridge several local evidence gaps for label expansion plan.
- Designed first nationwide SMA newborn screening test strategy thru innovative collaboration with external partners.
- Designed and organized first Asia Pacific SMA expert advisory meeting and worldwide Gene therapy symposium ( w/ 3000 plus participants).
- Served as subject expert to provide medical insights and strategies to cross functional teams and innovative partners(start-up collaborators).
Cosentyx Medical Science Liaison
Novartis Korea
01.2020 - 02.2021
- Achieve top 1 medical voice of share and top 2 medical engagement among all brands with rheumatologic indication via excellent medical expert (ME) field engagement.
- Lead digital ME engagement plans using different tools.
- Manage monthly APAC scientific webinar symposium.
- Provide medical and scientific educational session to cross functional teams.
Research associate
Yonsei College Of Medicine
01.2016 - 01.2021
- Created researches projects.
- Worked on various translational and academic research by analyzing the genomic and transcriptomic data
- Integrative EMR and genomic data analysis.
Education
Ph.D Candidate - Bioinformatics
Yonsei University
Seoul, South Korea 03.2017 - 07.2022
Medical Doctor (MD) - Medicine
University of Santo Tomas
Manila, Philippines 06.2004 - 05.2009
Bachelor of Science majored in Applied Biology - Applied Biology
De La Salle University – Dasma
Dasma, Philippines 06.2000 - 05.2004
Skills
Problem solving
undefinedPublications
- Characterizing intrinsic molecular features of the immune subtypes of salivary mucoepidermoid carcinoma, Translational Oncology, 2022, https://doi.org/10.1016/j.tranon.2022.101496
- Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis, Sci Rep, 2022, https://doi.org/10.1038/s41598-022-10182-3
- WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis, Arthritis Res Ther, 2021, https://doi.org/10.1186/s13075-021-02670-0
- Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers, Journal for ImmunoTherapy of Cancer, 2021, https://doi.org/10.1136/jitc-2021-003414
- Clonorchis sinensis-Derived Protein Attenuates Inflammation and New Bone Formation in Ankylosing Spondylitis, Front Immunol, 2021, https://doi.org/10.3389/fimmu.2021.615369
- Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response, Br J Cancer, 2020, https://doi.org/10.1038/s41416-020-0796-8
- Characteristic gene alterations in primary gastrointestinal T and NK cell lymphomas, Leukemia, 2019
- Somatic mutation driven codon transition bias in human cancer, Scientific Reports, 2017
Timeline
Data scientist
Novartis Korea
11.2022 - Current
Gene Therapy (Zolgensma) Medical Lead
Novartis Korea
03.2021 - 10.2022
Cosentyx Medical Science Liaison
Novartis Korea
01.2020 - 02.2021
Ph.D Candidate - Bioinformatics
Yonsei University
03.2017 - 07.2022
Research associate
Yonsei College Of Medicine
01.2016 - 01.2021
Medical Doctor (MD) - Medicine
University of Santo Tomas
06.2004 - 05.2009
Bachelor of Science majored in Applied Biology - Applied Biology
De La Salle University – Dasma
06.2000 - 05.2004
Similar Profiles
Eunmi Heather KimEunmi Heather Kim
Legal Manager at JT International KoreaLegal Manager at JT International Korea
SeungHeon HanSeungHeon Han
IT Service Desk Manager at Mercedes-Benz Korea, Mercedes-Benz Financial Service Korea, Mercedes-Benz Mobility KoreaIT Service Desk Manager at Mercedes-Benz Korea, Mercedes-Benz Financial Service Korea, Mercedes-Benz Mobility Korea
YEIZI PARKYEIZI PARK
Service Coordinator at JRC KOREA (ALPHATRON MARINE KOREA)Service Coordinator at JRC KOREA (ALPHATRON MARINE KOREA)